For the Inventor, By the Inventor

Enter assignee name

Fort Washington, PA, United States of America

Rorer Pharmaceutical Corporation

USPTO Granted Patents = 109

Trademarks = 1

Forward Citations = 1,405

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Henry F Campbell (45 out of 89 patents)

Donald E Kuhla (35 out of 59 patents)

William L Studt (31 out of 80 patents)

4. John T Suh (11 out of 49 patents)

5. Raymond D Youssefyeh (10 out of 27 patents)

6. William C Faith (9 out of 11 patents)

7. John R Regan (8 out of 51 patents)

8. Bruce F Molino (8 out of 22 patents)

9. Kent W Neuenschwander (8 out of 27 patents)

10. Robert A Galemmo, Jr (8 out of 27 patents)

11. Wayne M Grim (8 out of 10 patents)

12. Jerry W Skiles (7 out of 23 patents)

13. Stuart A Dodson (6 out of 25 patents)

14. Avinash M Contractor (6 out of 6 patents)

15. Alfred P Spada (5 out of 52 patents)

Core Competencies:

Anti-Thrombotic Peptides

HMG-CoA Reductase Inhibitors

Cardiotonic Compositions

Pharmaceutical Formulations

Quinoline Derivatives

Hypersensitivity Treatments

Calcitonin Analogues

Pharmacological Methods

Aryl Compounds

Bicyclic Ethers

Antiallergy Compounds

Peptic Ulcer Treatments

109 patents: Sort by Forward Citations

1. 5086069 - Anti-thrombotic peptide and pseudopeptide derivatives (1992-02-04),

2. 5026709 - Method for the preparation of a theophylline sustained release (1991-06-25),

3. 5002771 - Calcitonin suppository formulations (1991-03-26),

4. 4977246 - High recovery process for antihemophilic factor (1990-12-11),

5. 4977162 - Quinolinyl-chromone derivatives and use for treatment of hypersensitive (1990-12-11),

6. 4959485 - Hexahydrodibenzofuran carboxylic acid derivatives (1990-09-25),

7. 4954494 - Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in (1990-09-04),

8. 4952562 - Anti-thrombotic peptides and pseudopeptides (1990-08-28),

9. 4948582 - Treatment of conditions requiring enhanced oxygen availability to (1990-08-14),

10. 4946860 - Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors (1990-08-07),

11. 4944829 - Apparatus for applying wrappers (1990-07-31),

12. 4939143 - Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors (1990-07-03),

13. 4935511 - Benzoxazine and benzoxazepine carboxamide 5-HT.sub.3 antagonists (1990-06-19),

14. 4933445 - Heteroazabenzobicyclic carboxamide 5-HT.sub.3 antagonists (1990-06-12),

15. 4924010 - Benzoxepins as intermediates to 5HT.sub.3 antagonists (1990-05-08),

Rorer Pharmaceutical Corporation is a leading global pharmaceutical company specializing in the research, development, and production of innovative medicines. With a strong commitment to improving patient health and well-being, Rorer Pharma offers a wide range of effective and safe prescription drugs across various therapeutic areas. Our dedicated team of scientists, researchers, and professionals work tirelessly to deliver breakthrough treatments that address the unmet medical needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

109 Patents

#3 in Fort Washington, PA

#137 in Pennsylvania

#3,496 in US

#7,208 in the World

Fort Washington, PA, United States of America

Rorer Pharmaceutical Corporation

Forward Citations = 1,405

99 inventors:

Henry F Campbell (45 out of 89 patents)

Donald E Kuhla (35 out of 59 patents)

William L Studt (31 out of 80 patents)

4. John T Suh (11 out of 49 patents)

5. Raymond D Youssefyeh (10 out of 27 patents)

Please report any incorrect information to [email protected]

Loading…